deltatrials
Completed PHASE4 INTERVENTIONAL 1-arm NCT03460158

Prospective Evaluation of Facial Cosmetic Procedures

Prospective Evaluation of Minimally Invasive Facial Cosmetic Procedures Through Measured Volumetric Changes and Patient Reported Outcomes

Sponsor: Galderma R&D

Conditions Cosmetic Techniques
Interventions Restylane Silk® Restylane-L® Restylane-L® Lyft
Updated 19 times since 2018 Last updated: Sep 23, 2024 Started: Aug 21, 2020 Primary completion: Feb 28, 2024 Completion: May 29, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cosmetic Techniques and is currently completed. Galderma R&D leads this study, which shows 19 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Mar 2019 · 8 months · monthly snapshot~Mar 2019 – ~Jun 2019 · 3 months · monthly snapshot~Jun 2019 – ~Apr 2020 · 10 months · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Nov 2022 · 11 months · monthly snapshot~Nov 2022 – ~Jan 2023 · 2 months · monthly snapshot~Jan 2023 – ~Feb 2024 · 13 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – present · 21 months · monthly snapshot

Change History

19 versions recorded

  1. Oct 2024 — Present [monthly]

    Completed PHASE4

    Status: Active Not Recruiting → Completed

  2. Sep 2024 — Oct 2024 [monthly]

    Active Not Recruiting PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE4

  4. Feb 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE4

    Status: Recruiting → Active Not Recruiting

  5. Jan 2023 — Feb 2024 [monthly]

    Recruiting PHASE4

▶ Show 14 earlier versions

  1. Nov 2022 — Jan 2023 [monthly]

    Recruiting PHASE4

  2. Dec 2021 — Nov 2022 [monthly]

    Recruiting PHASE4

  3. Sep 2021 — Dec 2021 [monthly]

    Recruiting PHASE4

  4. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE4

  5. Sep 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  6. Aug 2020 — Sep 2020 [monthly]

    Not Yet Recruiting PHASE4

  7. Jul 2020 — Aug 2020 [monthly]

    Not Yet Recruiting PHASE4

  8. May 2020 — Jul 2020 [monthly]

    Not Yet Recruiting PHASE4

  9. Apr 2020 — May 2020 [monthly]

    Not Yet Recruiting PHASE4

  10. Jun 2019 — Apr 2020 [monthly]

    Not Yet Recruiting PHASE4

  11. Mar 2019 — Jun 2019 [monthly]

    Not Yet Recruiting PHASE4

  12. Jul 2018 — Mar 2019 [monthly]

    Not Yet Recruiting PHASE4

  13. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting PHASE4

  14. Mar 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Galderma R&D
  • University of Pennsylvania
Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations